Zevra Reports Q3 2026 Financial Results and Corporate Update
Zevra reported Q3 2026 net revenue of $37.8 million, including $34.0 million from MIPLYFFA, and noted a strong cash position.
Story updates
09:08:28 PM UTC
SquawkNews
Zevra reported Q3 2026 net revenue of $37.8M, up 45% from Q3 2025, including $34.0M from MIPLYFFA. Cash was $270.9M; no prior-period cash comparison was provided.Material DetailsContext by AI AnalystThis is an early commercial-stage update centered on MIPLYFFA revenue growth and the company's repor…
09:13:48 PM UTC
SquawkNews
Zevra Therapeutics reported third-quarter 2026 net revenue of $37.8 million, up 45% from a year earlier, and net income of $19.2 million. Diluted earnings were $0.26 per share, compared with a loss of $0.01 per share in the third quarter of 2025. The company ended September with $270.9 million in c…
$37.8 million net revenue for Q3 2026, driven by $34.0 million in revenue from MIPLYFFA45% increase in total net revenue over Q3 2025Operational execution fueled strong cash position of $270.9 millionCompany to host conference call and webcast TODAY, November 3, 2026, at 4:30 p.m. ETBOSTON, Mass…